As a multitude of studies have shown that Ang- (1-7) receptors can alleviate a myriad of metabolic diseases through Mas receptors and also counteract a range of adverse effects of Ang II, hypertensive drugs that block the action of Ang II can improve insulin resistance (74). This evidence concerns the gene AGT and metabolic disease.